Evidence map›Paper›PMID 37877314›Full record

ArticleCirculation. Arrhythmia and electrophysiology2023

Hypertrophic Cardiomyopathy and Ventricular Preexcitation in the Young: Cause and Accessory Pathway Characteristics.

Robert Przybylski, Sakethram Saravu Vijayashankar, Edward T O'Leary, Robyn J Hylind, Jennifer Noon, Audrey Dionne, Elizabeth S DeWitt, Vassilios J Bezzerides, Dominic J Abrams

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Arrhythmia and electrophysiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Ablation of manifest accessory pathways in pediatric patients: comparison between conventional and non‑radiological navigation techniques.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  2. The Year in Pediatric Electrophysiology: 2023.The Journal of innovations in cardiac rhythm management · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Robert PrzybylskiDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0001-7938-0998
Sakethram Saravu VijayashankarDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0003-2762-3390
Edward T O'LearyDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0001-8360-9820
Robyn J HylindDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0002-8280-4541
Jennifer NoonDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0009-0000-4258-484X
Audrey DionneDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0003-2864-1830
Elizabeth S DeWittDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.
Vassilios J BezzeridesDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0003-0825-6580
Dominic J AbramsDepartment of Cardiology, Boston Children's Hospital, Harvard Medical School, MA.ORCID 0000-0001-5266-2805
Boston Children's Hospital · US

Funding

RESEARCH METHODS IN PEDIATRICS HEART DISEASET32HL007572 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI Sarah D DE FERRANTI, Jane W. Newburger · 1985 to 2026
$13.0M
NHLBI NIH HHS T32 HL007572
6 · The paper itself

Abstract

backgroundThe cause of hypertrophic cardiomyopathy (HCM) in the young is highly varied. Ventricular preexcitation (preexcitation) is well recognized, yet little is known about the specificity for any cause and the characteristics of the responsible accessory pathways (AP).

methodsRetrospective cohort study of patients <21 years of age with HCM/preexcitation from 2000 to 2022. The cause of HCM was defined as isolated HCM, storage disorder, metabolic disease, or genetic syndrome. Atrioventricular AP (true AP) were distinguished from fasciculoventricular fibers (FVF) using standard invasive electrophysiology study criteria. AP were defined as high risk if any of the following were <250 ms: shortest preexcited RR interval in atrial fibrillation, shortest paced preexcited cycle length, or anterograde AP effective refractory period.

resultsWe identified 345 patients with HCM and 28 (8%) had preexcitation (isolated HCM, 10/220; storage disorder, 8/17; metabolic disease, 5/19; and genetic syndrome, 5/89). Six (21%) patients had clinical atrial fibrillation (1 with shortest preexcited RR interval <250 ms). Twenty-two patients underwent electrophysiology study which identified 23 true AP and 16 FVF. Preexcitation was exclusively FVF mediated in 8 (36%) patients. Five (23%) patients had AP with high-risk conduction properties (including ≥1 patient in each etiologic group). Multiple AP were seen in 8 (36%) and AP plus FVF in 10 (45%) patients. Ablation was acutely successful in 13 of 14 patients with recurrence in 3. One procedure was complicated by complete heart block after ablation of a high-risk midseptal AP. There were significant differences in QRS amplitude and delta wave amplitude between groups. There were no surface ECG features that differentiated AP from FVF.

conclusionsYoung patients with HCM and preexcitation have a high likelihood of underlying storage disease or metabolic disease. Nonisolated HCM should be suspected in young patients with large QRS and delta wave amplitudes. Surface ECG is not adequate to discriminate preexcitation from a benign FVF from that secondary to potentially life-threatening AP.

Indexed as

Accessory Atrioventricular BundleAtrial FibrillationCardiomyopathy, HypertrophicMetabolic DiseasesPre-Excitation SyndromesWolff-Parkinson-White SyndromeElectrocardiographyHumansRetrospective Studiesatrioventricular nodefasciculoventricular fibermetabolic diseasesphenotypeprognosis

Identifiers

PMID37877314
PMCPMC10843507
OpenAlexW4387931308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.